Researchers at Johns Hopkins Medicine in Baltimore have devised a new way to assess precise treatments for people with multiple sclerosis (MS). They are looking deeply into patients’ eyes. By measuring the optic nerves in patients, researchers can gauge how much overall neurological damage has occurred in people with MS – bringing doctors closer to a significant advance in halting the progressive disease. After collecting the data from those optic measurements, Johns Hopkins Medicine worked with Microsoft to apply artificial intelligence and machine learning tools to create individualized treatments for each patient.
Subscribe to Microsoft on YouTube here: https://aka.ms/SubscribeToYouTube
Follow us on social:
LinkedIn: https://www.linkedin.com/company/microsoft/
Twitter: https://twitter.com/Microsoft
Facebook: https://www.facebook.com/Microsoft/
Instagram: https://www.instagram.com/microsoft/
For more about Microsoft, our technology, and our mission, visit https://aka.ms/microsoftstories
